Atlas of Postmenopausal Osteoporosis (Record no. 7582)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03676nam a22002897a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240305192511.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 220719b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 1907673288 |
| International Standard Book Number | 9781907673283 |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | DLC |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.723 RIZ |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Rene Rizzoli |
| 9 (RLIN) | 40129 |
| 222 ## - KEY TITLE | |
| Key title | activity alendronate Ammann assessment associated bisphosphonates bone density bone formation bone loss Bone Miner Res bone mineral density Bone Quality bone remodeling bone resorption bone strength bone tissue bone turnover calcitonin calcium clinical compared with placebo cortical thickness decreased denosumab Diagnosis of Postmenopausal EnglJ Epidemiology and Diagnosis femoral neck fracture in women fracture risk fractures Figure Genant hip fracture ibandronate incidence increased bone intake Kanis lumbar spine markers menopause microarchitecture mineral density BMD nonvertebral fractures osteoclasts osteocytes Osteoporos Int osteoporotic fractures ovariectomized parathyroid hormone Pathophysiology of Postmenopausal patients placebo Postmenopausal Osteoporosis Postmenopausal Osteoporosis Effect postmenopausal women Prevention and Treatment protein Quality and Strength radiograph raloxifene RANKL rats Reproduced with permission risedronate risk factors risk of fracture risk of hip risk of vertebral Rizzoli skeletal strontium ranelate T-score total hip trabecular bone Treatment of Postmenopausal trial vertebral fractures vitamin women with osteoporosis |
| 245 ## - TITLE STATEMENT | |
| Title | Atlas of Postmenopausal Osteoporosis |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 3rd edition, illustrated, revised |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | London |
| Name of publisher, distributor, etc. | Springer Science & Business Media |
| Date of publication, distribution, etc. | 2011 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 118 pages |
| 511 ## - PARTICIPANT OR PERFORMER NOTE | |
| Participant or performer note | Contents:<br/><br/>Chapter 1 Pathophysiology of postmenopausal osteoporosis<br/><br/>Chapter 2 Epidemiology and diagnosis ofpostmenopausal osteoporosis<br/><br/>Chapter 3 Bone quality and strength<br/><br/>Chapter 4 Prevention and treatment of postmenopausalosteoporosis<br/><br/>Chapter 5 Conclusion<br/><br/>Index<br/> |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | René Rizzoli Menopause is the time in a woman’s life when reproductive capacity ends. Ovaries decrease their activity and the production of sex hormones ceases. This period may be associated with a large variety of symptoms affecting the cardiovascular and urogenital systems, as well as skin, hair and bone. Bone capital is accumulated by the end of the second decade and remains more or less constant up to the time of menopause. Sex hormone deficiency leads to accelerated bone turnover, a negative balance and microarchitectural deterioration, which compromises bone strength, thereby increasing bone fragility and, thus, fracture risk. By the age of 80, it is estimated that 50% of trab- ular bone will have been lost. Natural menopause occurs between the ages of 45 and 54 years all over the world. This age does not appear to have changed significantly over the centuries. In contrast, since the middle of the 19th century, life expectancy, particularly in women, has increased considerably, with most women living to the age of 80 years or more in many regions of the world. This means that at the age of 50 years, a woman will live for more than 30 years without bone protection by sex hormones. This r- resents more than one-third of a woman’s life. At the age of 50 years, the lifetime risk to experience a fracture is about 50% (ie, one out of two women will have a fracture during this period). |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| General subdivision | Medical / Rheumatology |
| 9 (RLIN) | 26925 |
| General subdivision | Medical / Orthopedics |
| 9 (RLIN) | 26926 |
| General subdivision | Medical / Gynecology & Obstetrics |
| 9 (RLIN) | 26832 |
| General subdivision | Medical / Clinical Medicine |
| 9 (RLIN) | 26816 |
| General subdivision | Medical › Rheumatology |
| 9 (RLIN) | 32171 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | ddc |
| Koha item type | BOOKS |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection | Home library | Current library | Shelving location | Date acquired | Total checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 07/19/2022 | 616.723 RIZ | EBS11974 | 07/19/2022 | 07/19/2022 | E-BOOKS |